Latest news from TeraDiscoveries on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/teradiscoveries-announces-the-design-of-six-new-drugs-in-silico-as-part-of-strategic-relationship/?sc=rsin /articles/teradiscoveries-announces-the-design-of-six-new-drugs-in-silico-as-part-of-strategic-relationship/?sc=rsin Thu, 14 Jun 2012 09:00:00 EST TeraDiscoveries, Inc., announced today the identification of the first six biological targets for which the company is designing new drug candidates. This development follows the formation of a strategic relationship TeraDiscoveries has established with Microsoft Corp. Microsoft is providing support and cloud computing time on Windows Azure that TeraDiscoveries is applying to identify inhibitors of 25 top biological targets. The first six targets, which are now undergoing computer modeling, are HDAC8, JAK3, JAK2, PGP, HSP90, and the thioredoxin/glutathione reductase protein from the Schistosoma parasite. TeraDiscoveries